Thomas J. McLellan

605 total citations
10 papers, 309 citations indexed

About

Thomas J. McLellan is a scholar working on Molecular Biology, Pharmacology and Genetics. According to data from OpenAlex, Thomas J. McLellan has authored 10 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 2 papers in Pharmacology and 2 papers in Genetics. Recurrent topics in Thomas J. McLellan's work include RNA modifications and cancer (3 papers), Amino Acid Enzymes and Metabolism (2 papers) and Bacterial Genetics and Biotechnology (2 papers). Thomas J. McLellan is often cited by papers focused on RNA modifications and cancer (3 papers), Amino Acid Enzymes and Metabolism (2 papers) and Bacterial Genetics and Biotechnology (2 papers). Thomas J. McLellan collaborates with scholars based in United States, United Kingdom and Canada. Thomas J. McLellan's co-authors include Michele A. Kelly, Kieran F. Geoghegan, Jayvardhan Pandit, Ann Aulabaugh, Jean‐Pierre Pelletier, Peter Mézeš, James T. Downs, George A. Karam, Ivan G. Otterness and C L Lane and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Analytical Chemistry and Analytical Biochemistry.

In The Last Decade

Thomas J. McLellan

10 papers receiving 300 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas J. McLellan United States 8 187 67 56 40 37 10 309
Stephen J. Mnich United States 8 233 1.2× 121 1.8× 35 0.6× 106 2.6× 23 0.6× 8 459
Mitsuyuki Kuroki United States 10 245 1.3× 35 0.5× 19 0.3× 20 0.5× 64 1.7× 11 461
Elisa Bjørgo Norway 11 321 1.7× 22 0.3× 36 0.6× 10 0.3× 28 0.8× 15 543
Michael Yeadon United Kingdom 11 138 0.7× 16 0.2× 46 0.8× 67 1.7× 10 0.3× 17 455
Yuki Nagano Japan 8 272 1.5× 52 0.8× 12 0.2× 61 1.5× 12 0.3× 12 419
Rashmi Talwar India 11 137 0.7× 46 0.7× 21 0.4× 45 1.1× 26 0.7× 22 298
Jonas Hansen Denmark 12 351 1.9× 19 0.3× 23 0.4× 39 1.0× 18 0.5× 17 474
Sara Bianco Italy 13 309 1.7× 34 0.5× 12 0.2× 25 0.6× 13 0.4× 19 465
Nina Ondrušková Czechia 9 290 1.6× 15 0.2× 44 0.8× 46 1.1× 20 0.5× 17 358
Masashi Kawanishi Japan 13 262 1.4× 77 1.1× 18 0.3× 140 3.5× 6 0.2× 21 422

Countries citing papers authored by Thomas J. McLellan

Since Specialization
Citations

This map shows the geographic impact of Thomas J. McLellan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas J. McLellan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas J. McLellan more than expected).

Fields of papers citing papers by Thomas J. McLellan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas J. McLellan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas J. McLellan. The network helps show where Thomas J. McLellan may publish in the future.

Co-authorship network of co-authors of Thomas J. McLellan

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas J. McLellan. A scholar is included among the top collaborators of Thomas J. McLellan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas J. McLellan. Thomas J. McLellan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Conti, Brooke A., Qing Xiang, Thomas J. McLellan, et al.. (2024). N6-methyladenosine in DNA promotes genome stability. eLife. 13. 1 indexed citations
2.
Yu, Xiaodi, Olga Plotnikova, Paul D. Bonin, et al.. (2019). Cryo-EM structures of the human glutamine transporter SLC1A5 (ASCT2) in the outward-facing conformation. eLife. 8. 54 indexed citations
3.
Aulabaugh, Ann, et al.. (2015). Engineered stabilization and structural analysis of the autoinhibited conformation of PDE4. Proceedings of the National Academy of Sciences. 112(12). E1414–22. 61 indexed citations
4.
Atkinson, Karen, Elena Beretta, Janice A. Brown, et al.. (2011). N-Benzylimidazole carboxamides as potent, orally active stearoylCoA desaturase-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(6). 1621–1625. 35 indexed citations
5.
McLellan, Thomas J., Eric S. Marr, L Wondrack, et al.. (2009). A systematic study of 50S ribosomal subunit purification enabling robust crystallization. Acta Crystallographica Section D Biological Crystallography. 65(12). 1270–1282. 14 indexed citations
6.
Simons, Samuel P., Thomas J. McLellan, Paul A. Aeed, et al.. (2009). Purification of the large ribosomal subunit via its association with the small subunit. Analytical Biochemistry. 395(1). 77–85. 6 indexed citations
7.
Soares, Holly, Travis T. Wager, Anne W. Schmidt, et al.. (2009). P1‐264: H3 receptor antagonism increases methylhistamine levels in the cerebrospinal fluid of dogs and healthy human volunteers. Alzheimer s & Dementia. 5(4S_Part_8). 7 indexed citations
8.
Snaith, J. S., Richard F. W. Jackson, Andrew B. McElroy, et al.. (2002). Synthesis of Macrocyclic, Potential Protease Inhibitors Using a Generic Scaffold. The Journal of Organic Chemistry. 67(14). 4882–4892. 29 indexed citations
9.
Downs, James T., C L Lane, Thomas J. McLellan, et al.. (2001). Analysis of collagenase-cleavage of type II collagen using a neoepitope ELISA. Journal of Immunological Methods. 247(1-2). 25–34. 74 indexed citations
10.
Kelly, Michele A., et al.. (2001). Strategic Use of Affinity-Based Mass Spectrometry Techniques in the Drug Discovery Process. Analytical Chemistry. 74(1). 1–9. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026